Latest posts
-
Faster, Smarter, or Left Behind: FDA’s Clinical Modernization Mandate
1,294 words5–8 minutesFDA Actions to Accelerate and Modernize Early and Late-Stage Clinical Development Senior Pharmaceutical Quality, Regulatory Affairs & Manufacturing Expert | Thought Leadership Series The FDA’s modernization agenda is not a future promise — it is actively reshaping how drugs are developed, reviewed, and approved today. If your organization’s clinical strategy still mirrors pre-2020 assumptions, you…
-
PUPSIT: Why It Matters More Than Ever
1,298 words5–8 minutesMost sterile manufacturers know what PUPSIT stands for. Far fewer have a program they’d be confident defending under inspector scrutiny. Here is what regulators expect, how industry has responded, and what you should actually be doing. The author is a senior pharmaceutical quality, regulatory affairs, and manufacturing consultant with more than 20 years of experience…